Dopaminergic-cholinergic imbalance in movement disorders: a role for the novel striatal dopamine D(2)- muscarinic acetylcholine M(1) receptor heteromer

por Crans, René A. J., Ciruela, Francisco
Publicado 2020

Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art

por Wouters, Elise, Vasudevan, Lakshmi, Crans, René A. J., Saini, Deepak K., Stove, Christophe P.
Publicado 2019

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A

por vel Szic, Katarzyna Szarc, Declerck, Ken, Crans, René A.J, Diddens, Jolien, Scherf, David B., Gerhäuser, Clarissa, Berghe, Wim Vanden
Publicado 2017

Striatal Dopamine D(2)-Muscarinic Acetylcholine M(1) Receptor–Receptor Interaction in a Model of Movement Disorders

por Crans, René A. J., Wouters, Elise, Valle-León, Marta, Taura, Jaume, Massari, Caio M., Fernández-Dueñas, Víctor, Stove, Christophe P., Ciruela, Francisco
Publicado 2020

Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders

por Crans, René A. J., Wouters, Elise, Valle-León, Marta, Taura, Jaume, Massari, Caio M., Fernández-Dueñas, Víctor, Stove, Christophe P., Ciruela, Francisco
Publicado 2022

The validation of Short Interspersed Nuclear Elements (SINEs) as a RT-qPCR normalization strategy in a rodent model for temporal lobe epilepsy

por Crans, René A. J., Janssens, Jana, Daelemans, Sofie, Wouters, Elise, Raedt, Robrecht, Van Dam, Debby, De Deyn, Peter P., Van Craenenbroeck, Kathleen, Stove, Christophe P.
Publicado 2019

The mGlu(5) Receptor Protomer-Mediated Dopamine D(2) Receptor Trans-Inhibition Is Dependent on the Adenosine A(2A) Receptor Protomer: Implications for Parkinson’s Disease

por Romero-Fernandez, Wilber, Taura, Jaume J., Crans, René A. J., Lopez-Cano, Marc, Fores-Pons, Ramon, Narváez, Manuel, Carlsson, Jens, Ciruela, Francisco, Fuxe, Kjell, Borroto-Escuela, Dasiel O.
Publicado 2022